Your browser doesn't support javascript.
loading
Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS.
Kearns, James T; Faino, Anna V; Schenk, Jeanette M; Newcomb, Lisa F; Brooks, James D; Carroll, Peter R; Dash, Atreya; Ellis, William J; Fabrizio, Michael; Gleave, Martin E; Morgan, Todd M; Nelson, Peter S; Thompson, Ian M; Wagner, Andrew; Zheng, Yingye; Lin, Daniel W.
Affiliation
  • Kearns JT; Department of Urology, University of Washington School of Medicine, Seattle, Washington.
  • Faino AV; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Schenk JM; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Newcomb LF; Seattle, Washington.
  • Brooks JD; Stanford University, San Francisco, California.
  • Carroll PR; Stanford and University of California-San Francisco, San Francisco, California.
  • Dash A; Department of Urology, University of Washington School of Medicine, Seattle, Washington.
  • Ellis WJ; Department of Urology, University of Washington School of Medicine, Seattle, Washington.
  • Fabrizio M; Eastern Virginia Medical School, Norfolk, Virginia.
  • Gleave ME; University of British Columbia, Vancouver, British Columbia, Canada.
  • Morgan TM; University of Michigan, Ann Arbor, Michigan.
  • Nelson PS; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Thompson IM; University of Texas Health Sciences Center at San Antonio, San Antonio, Texas.
  • Wagner A; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Zheng Y; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Lin DW; Seattle, Washington.
J Urol ; 201(1): 106-111, 2019 01.
Article in En | MEDLINE | ID: mdl-30076904
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Population Surveillance / 5-alpha Reductase Inhibitors Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Population Surveillance / 5-alpha Reductase Inhibitors Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: J Urol Year: 2019 Document type: Article Country of publication: United States